SCHEMBL9837170

SCHEMBL9837170

COC(=O)C(SC(C)=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.44
BRD4 O60885 1/20 0.43
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
SLC6A2 P23975 1/20 0.42
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
FFAR2 O15552 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607240 0.85 L3MBTL1 (0.41) L3MBTL1SMN1; SMN2KMT2A
SCHEMBL12607239 0.83 CYP1A2 (0.47) CNR1HPGDSMN1; SMN2KMT2A
SCHEMBL12651031 0.83 NPSR1 (0.47) HDAC4HDAC7HDAC5CNR2SMN1; SMN2
SCHEMBL12607247 0.83 HDAC3 (0.40) HDAC4HDAC7HDAC5GAAKMT2A
SCHEMBL12607237 0.83 SLC6A3 (0.51) SLC6A4SLC6A3SLC6A2SMN1; SMN2
SCHEMBL12607241 0.81 KMT2A (0.44) SLC6A3HPGDSMN1; SMN2KMT2A
SCHEMBL12607238 0.81 MAPT (0.40) SLC6A2KMT2A
SCHEMBL12607246 0.81 ESR1 (0.42) L3MBTL1HPGDSMN1; SMN2KMT2A
SCHEMBL3518534 0.80 CYP2C9 (0.51) TRPA1L3MBTL1SLC6A4SLC6A3SLC6A2
SCHEMBL11849223 0.80 PGR (0.44) L3MBTL1SLC6A4SLC6A3GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246343-B1 PROCESS FOR PRODUCTION OF THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL IND LTD (JP) 2016-05-18 EP disclosed
US-8642786-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-02-04 US disclosed
US-8642786-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-02-04 US disclosed
US-20130204013-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-08-08 US disclosed
US-20130204013-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-08-08 US disclosed
US-8420849-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-04-16 US disclosed
US-8420849-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-04-16 US disclosed
US-8399685-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-19 US disclosed
US-8399685-B2 Process for producing thiophene compound and intermediate thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-19 US disclosed
US-20130060050-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-07 US disclosed
US-20130060050-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-07 US disclosed
US-20110124884-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-05-26 US disclosed
US-20110124884-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-05-26 US disclosed
EP-0256687-B1 THIAZOLIDIN-4-ONE DERIVATIVES AND ACID ADDITION SALTS THEREOF SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1991-06-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130060050-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF SULT1E1, CYP3A4, TKT TRPA1 1545/4885L3MBTL1 3016/4885BRD4 1421/4885
US-20130204013-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF TST, SULT1E1, GRHPR TRPA1 649/4885L3MBTL1 2553/4885BRD4 2139/4885
US-20110124884-A1 PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF TST, SULT1E1, GRHPR TRPA1 649/4885L3MBTL1 2553/4885BRD4 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.